Published online Oct 18, 2013. doi: 10.5312/wjo.v4.i4.316
Revised: July 7, 2013
Accepted: July 12, 2013
Published online: October 18, 2013
Core tip: The effects of risedronate treatment on quantitative ultrasound parameters of the calcaneus remain to be established in patients with osteoporosis. The aim of the present clinical practice-based observational study was to examine the effects of treatment with risedronate for 1 year on speed of sound (SOS) of the calcaneus and bone turnover markers in postmenopausal women with osteoporosis. The present study confirmed that risedronate suppressed bone turnover and elicited a clinically significant increase in the SOS of the calcaneus in postmenopausal women with osteoporosis.